Jury Deliberations Continue in 'Pharma Bro' Martin Shkreli's Securities Fraud Case - NBC New York

Chief Investigative Reporter Jonathan Dienst on crime, corruption and terrorism.

Jury Deliberations Continue in 'Pharma Bro' Martin Shkreli's Securities Fraud Case

    processing...

    NEWSLETTERS

    Martin Shkreli's Fraud Trial to Begin Monday

    Ex-pharmaceutical CEO Martin Shkreli's fraud trial is set to begin Monday. Lori Bordonaro reports.

    (Published Monday, June 26, 2017)

    Jurors have deliberated for a second day at the federal securities fraud trial of former pharmaceutical company CEO Martin Shkreli.

    They got the case Monday in New York and spent a full day deliberating Tuesday before ending the day without a verdict. Deliberations resume Wednesday.

    Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.

    The former biotech CEO - nicknamed "Pharma Bro" - is best known for hiking up the price of a life-saving drug and for trolling his critics on social media.

    Family Says Vaping Killed Their 28-Year-Old Son

    [NATL] Family Says Vaping Killed Their 28-Year-Old Son
    An Orlando family is grieving the loss of their 28-year-old son, who died last week. They said he died as a result of vaping. Kyle Boyd's mother, Kimberly, said he was fine last Monday after he came home from hanging out with a group of friends. She said the next morning she could not wake him up.
     
    (Published Thursday, Nov. 21, 2019)

    If convicted of the most serious counts, he could face up to 20 years in prison but likely would receive far less time under sentencing guidelines.

    Get the latest from NBC 4 New York anywhere, anytime

    • Download the App

      Available for IOS and Android